Quality indicators in lung cancer: a review and analysis

Abstract

Contributed to conception of design, analysis and interpretation of data, final approval. SKV: Contributed to conception of design, analysis and interpretation of data, critical revision of work, final approval. PS: Contributed to conception of design, critical revision of work, final approval. BJ: Contributed to conception of design, critical revision of work and final approval. SC: Contributed to conception of design, critical revision of work and final approval.

Quality indicators for acute cardiovascular diseases: a scoping review

“…Most of the various QI measurements were categorized as process measurements. This finding is consistent with those of previous reviews on non-cardiovascular diseases [ 44 , 45 ]. The QI measurements in our study were used in a variety of situations (upon admission, acute setting, during hospitalization / at discharge).…”

Quality indicators for radiation oncology

“…1). To date, the majority of oncology QIs are process‐based and disproportionately weighted towards the effectiveness and safety of surgical procedures with very limited radiation oncology QIs (ROQIs) 3–6 . Albert and Das highlighted the particular challenges for developing and updating relevant oncology QIs to incorporate all the evolving changes in best practice with evidence‐based trials of novel treatments and technologies 4 .…”

“…Several tumour site‐specific sets of ROQIs have been proposed. These are commonly developed subsequent to the evident paucity of ROQIs within general tumour site‐specific oncology QI publications 3,5,17 …”

“…To date, the majority of oncology QIs are process-based and disproportionately weighted towards the effectiveness and safety of surgical procedures with very limited radiation oncology QIs (ROQIs). [3][4][5][6] Albert and Das highlighted the particular challenges for developing and updating relevant oncology QIs to incorporate all the evolving changes in best practice with evidence-based trials of novel treatments and technologies. 4 At the time of their report, QIs developed for measuring quality of care in oncology tended to be tumour site-specific, focussing along the whole patient pathway, from diagnosis, through treatment to survivorship and end-of-life care, for example, as based on standards as developed for lung cancer by an international consortium.…”

“…These are commonly developed subsequent to the evident paucity of ROQIs within general tumour sitespecific oncology QI publications. 3,5,17 A Canadian group looked at Breast ROQIs initially with a literature search, followed by a modified Delphi process and then national survey. 24 For 22 Tier 1 indicatorsover 33% voted them as important and for 11 Tier 2 votes were lower but peer reviewed and measurable).…”